{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T23:05:49Z","timestamp":1769123149862,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T00:00:00Z","timestamp":1510012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heartlungcirc.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.hlc.2017.10.018","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T16:06:30Z","timestamp":1510589190000},"page":"1018-1027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3180-6993","authenticated-orcid":false,"given":"Robert","family":"Tulloh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kostas","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Condliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Clift","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2017.10.018_bib0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Galie","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijcard.2014.09.024","article-title":"Pulmonary arterial hypertension associated with congenital heart disease: recent advances and future directions","volume":"177","author":"Gatzoulis","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.018_bib0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0025","unstructured":"National Audit of Pulmonary Hypertension 2015 [21.12.2016]. Available from: http:\/\/content.digital.nhs.uk\/catalogue\/PUB20043\/nati-pulm-hype-audi-2015-rep.pdf."},{"key":"10.1016\/j.hlc.2017.10.018_bib0030","series-title":"NHS England New Congenital Heart Disease Review: Final Report","year":"2015"},{"key":"10.1016\/j.hlc.2017.10.018_bib0035","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1136\/bmj.2.5099.755","article-title":"The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt","volume":"2","author":"Wood","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12471-015-0666-9","article-title":"Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease","volume":"23","author":"Blok","year":"2015","journal-title":"Neth Heart J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0045","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1378\/chest.12-0528","article-title":"Management of pulmonary arterial hypertension during pregnancy: a retrospective, multicenter experience","volume":"143","author":"Duarte","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2017.10.018_bib0050","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1093\/eurheartj\/ehr130","article-title":"Iron deficiency is associated with adverse outcome in Eisenmenger patients","volume":"32","author":"Van De Bruaene","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1183\/09031936.00123711","article-title":"Safety and efficacy of exercise training in various forms of pulmonary hypertension","volume":"40","author":"Grunig","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hlc.2017.10.018_bib0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCULATIONAHA.106.618397","article-title":"Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension","volume":"114","author":"Mereles","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.018_bib0065","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.018_bib0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pcad.2012.06.002","article-title":"Arrhythmias in pulmonary arterial hypertension","volume":"55","author":"Rajdev","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.hlc.2017.10.018_bib0075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14779072.2016.1133294","article-title":"Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P","volume":"14","author":"Ministeri","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.hlc.2017.10.018_bib0080","doi-asserted-by":"crossref","unstructured":"Weaver H.A., Tulloh R.M.R. Thrombocytopenia in pulmonary hypertension, does it predict survival? 2013 [22.09.2016]. Available from: http:\/\/eurheartj.oxfordjournals.org\/content\/ehj\/34\/suppl_1\/P318.full.pdf.","DOI":"10.1093\/eurheartj\/eht307.P318"},{"key":"10.1016\/j.hlc.2017.10.018_bib0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/chd.12025","article-title":"Facilitators of and barriers to advance care planning in adult congenital heart disease","volume":"8","author":"Greutmann","year":"2013","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hlc.2017.10.018_bib0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SPC.0b013e3283492aa3","article-title":"Supportive and palliative care for adults dying from congenital heart defect","volume":"5","author":"Tobler","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.hlc.2017.10.018_bib0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/0269216311407694","article-title":"End-of-life care in hospitalized adults with complex congenital heart disease: care delayed, care denied","volume":"26","author":"Tobler","year":"2012","journal-title":"Palliat Med"},{"key":"10.1016\/j.hlc.2017.10.018_bib0100","unstructured":"National Audit of Pulmonary Hypertension 2014 [21.12.2016]. Available from: http:\/\/content.digital.nhs.uk\/catalogue\/PUB17264\/nati-pulm-hype-audi-2014-rep.pdf."},{"key":"10.1016\/j.hlc.2017.10.018_bib0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Galie","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.018_bib0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2007.04.078","article-title":"Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: results of the BREATHE-5 open-label extension study","volume":"127","author":"Gatzoulis","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.018_bib0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijcard.2016.11.211","article-title":"From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement","volume":"227","author":"Blok","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.018_bib0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1747-0803.2011.00561.x","article-title":"Clinical efficacy of phosphodiesterase-5 inhibitor tadalafil in Eisenmenger syndrome\u2013a randomized, placebo-controlled, double-blind crossover study","volume":"6","author":"Mukhopadhyay","year":"2011","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.hlc.2017.10.018_bib0125","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.105.603001","article-title":"Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study","volume":"114","author":"Mukhopadhyay","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.018_bib0130","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/01.CIR.99.14.1858","article-title":"Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects","volume":"99","author":"Rosenzweig","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.018_bib0135","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2017.10.018_bib0140","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2017.10.018_bib0145","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2017.10.018_bib0150","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2017.10.018_bib0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2017.10.018_bib0160","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1136\/heartjnl-2015-307832","article-title":"Riociguat for pulmonary arterial hypertension associated with congenital heart disease","volume":"101","author":"Rosenkranz","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.hlc.2017.10.018_bib0165","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hlc.2017.10.018_bib0170","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the Treatment of Pulmonary Arterial Hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.hlc.2019.10.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000}}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617314658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950617314658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T06:26:35Z","timestamp":1570170395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950617314658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1443950617314658"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2017.10.018","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.hlc.2019.10.004","asserted-by":"object"}]},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Adults With Congenital Heart Disease and Pulmonary Arterial Hypertension in the UK: Survey of Current Practice, Unmet Needs and Expert Commentary","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2017.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}